Home > Annual Financials > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS Financial Statement Analysis
[BOM: 539997]

The Revenues of KWALITY PHARMACEUTICALS have increased by 22.36% YoY .
The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has increased by 67.47 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

KWALITY PHARMACEUTICALS Last 5 Annual Financial Results
[BOM: 539997]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹307 Cr₹251 Cr₹456 Cr₹262 Cr₹139 Cr
Expenses ₹241 Cr₹190 Cr₹285 Cr₹233 Cr₹125 Cr
Operating Profit (Excl OI) ₹66 Cr₹61 Cr₹172 Cr₹29 Cr₹14 Cr
Other Income ₹1.83 Cr₹2.94 Cr₹3.51 Cr₹1.59 Cr₹3.66 Cr
Interest ₹10 Cr₹6.61 Cr₹2.92 Cr₹2.68 Cr₹2.50 Cr
Depreciation ₹20 Cr₹15 Cr₹11 Cr₹6.49 Cr₹4.43 Cr
Profit Before Tax ₹31 Cr₹26 Cr₹162 Cr₹21 Cr₹11 Cr
Profit After Tax ₹24 Cr₹19 Cr₹120 Cr₹15 Cr₹8.21 Cr
Consolidated Net Profit ₹24 Cr₹19 Cr₹120 Cr₹15 Cr₹8.32 Cr
Earnings Per Share (Rs)₹38.40₹22.93₹18.67₹115.64₹14.60
PAT Margin (%)10.757.697.6826.295.68
ROE(%)16.3611.1610.1599.6628.21
ROCE(%)18.3613.5712.2797.9326.35
Total Debt/Equity(x)0.430.440.450.300.68

Key Financials

Market Cap : ₹ 996.2 Cr
Revenue (TTM) : ₹ 401.6 Cr
Net Profit(TTM) : ₹ 43.4 Cr
EPS (TTM) : ₹ 41.7
P/E (TTM) : 23.0

Industry Peers & Returns1W1M1Y
KWALITY PHARMACEUTICALS -1.1% -6.7% 23.2%
SUN PHARMACEUTICAL INDUSTRIES 3.4% 1.3% -11.6%
DIVIS LABORATORIES 2.4% 3.2% 11.9%
CIPLA 1.8% 1.9% -5.6%
TORRENT PHARMACEUTICALS 2.8% -0.9% 3.3%
DR REDDYS LABORATORIES 1.7% 6.2% -0.3%
MANKIND PHARMA 3% 6.2% 7.5%
ZYDUS LIFESCIENCES 0% 5.5% -5.6%
LUPIN 0.5% 6% -9.9%


KWALITY PHARMACEUTICALS Revenues
[BOM: 539997]

Y-o-Y

22.36 %

5 Yr CAGR

21.86 %

Years Revenues % Change
Mar2025 ₹307 Cr
22.36
Mar2024 ₹251 Cr
-44.97
Mar2023 ₹456 Cr
74.11
Mar2022 ₹262 Cr
88.10
Mar2021 ₹139 Cr -


KWALITY PHARMACEUTICALS Operating Profit
[BOM: 539997]

Y-o-Y

9.20 %

5 Yr CAGR

47.02 %

Years Operating Profit % Change
Mar2025 ₹66 Cr
9.20
Mar2024 ₹61 Cr
-64.62
Mar2023 ₹172 Cr
494.98
Mar2022 ₹29 Cr
103.27
Mar2021 ₹14 Cr -

Operating Margins
Y-o-Y

-10.75 %

5 Yr CAGR

20.65 %

Years Operating Margin% % Change
Mar2025 21.59%
-10.75
Mar2024 24.19%
-35.72
Mar2023 37.63%
241.78
Mar2022 11.01%
8.05
Mar2021 10.19% -

KWALITY PHARMACEUTICALS Profit After Tax
[BOM: 539997]

Y-o-Y

22.83 %

5 Yr CAGR

30.06 %

Years Profit After Tax % Change
Mar2025 ₹24 Cr
22.83
Mar2024 ₹19 Cr
-83.85
Mar2023 ₹120 Cr
692.23
Mar2022 ₹15 Cr
82.11
Mar2021 ₹8.32 Cr -

PAT Margins
Y-o-Y

39.79 %

5 Yr CAGR

17.29 %

Years PAT Margin(%) % Change
Mar2025 10.75 %
39.79
Mar2024 7.69 %
0.13
Mar2023 7.68 %
-70.79
Mar2022 26.29 %
362.85
Mar2021 5.68 % -

KWALITY PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 539997]

Y-o-Y

67.47 %

5 Yr CAGR

27.35 %

Years EPS % Change
Mar2025 ₹38
67.47
Mar2024 ₹23
22.82
Mar2023 ₹19
-83.86
Mar2022 ₹116
692.05
Mar2021 ₹15 -

KWALITY PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 539997]

Y-o-Y

35.30 %

5 Yr CAGR

-8.64 %

Years ROCE % Change
Mar2025 18.36%
35.30
Mar2024 13.57%
10.59
Mar2023 12.27%
-87.47
Mar2022 97.93%
271.65
Mar2021 26.35% -

KWALITY PHARMACEUTICALS Share Price vs Sensex

Current Share Price : ₹957.9
Current MarketCap: ₹ 996.2 Cr
Updated EOD on :Sep 19,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-1.1%

-6.7%

23.2%

SENSEX

0.9%

1.2%

-0.4%

KWALITY PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
BSE ALLCAP 6.4% 8.9% 7.5%
BSE MIDSMALLCAP 4.7% 9% 8.4%
BSE SMALLCAP 2% 3% -4.7%
BSE HEALTHCARE 0.7% 1.5% 2%
No NSE index found

You may also like the below Video Courses


FAQ about KWALITY PHARMACEUTICALS Financials


How the annual revenues of KWALITY PHARMACEUTICALS have changed ?

The Revenues of KWALITY PHARMACEUTICALS have increased by 22.36% YoY .

How the Earnings per Share (EPS) of KWALITY PHARMACEUTICALS have changed?

The Earnings Per Share (EPS) of KWALITY PHARMACEUTICALS has increased by 67.47 % YoY .